PIK3CA and colorectal carcinoma: The PI3K/Akt/mTOR pathway is mutated in CRC patients (1% in AKT1, 2.4% in PIK3R1, 2.5% in PIK3CG, 2.8% in PTEN and 18% in PIK3CA) [5].